Dalit Landesman‐Milo

1.4k total citations
18 papers, 1.1k citations indexed

About

Dalit Landesman‐Milo is a scholar working on Molecular Biology, Biomaterials and Immunology. According to data from OpenAlex, Dalit Landesman‐Milo has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Biomaterials and 4 papers in Immunology. Recurrent topics in Dalit Landesman‐Milo's work include RNA Interference and Gene Delivery (12 papers), Advanced biosensing and bioanalysis techniques (7 papers) and Nanoparticle-Based Drug Delivery (6 papers). Dalit Landesman‐Milo is often cited by papers focused on RNA Interference and Gene Delivery (12 papers), Advanced biosensing and bioanalysis techniques (7 papers) and Nanoparticle-Based Drug Delivery (6 papers). Dalit Landesman‐Milo collaborates with scholars based in Israel, United States and Austria. Dalit Landesman‐Milo's co-authors include Dan Peer, Meir Goldsmith, Daniel F. Moyano, Vincent M. Rotello, Oscar R. Miranda, Srinivas Ramishetti, Shoshy Mizrahy, Inbal Hazan‐Halevy, Manu Smriti Singh and Niels Dammes and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Controlled Release and Small.

In The Last Decade

Dalit Landesman‐Milo

18 papers receiving 1.1k citations

Peers

Dalit Landesman‐Milo

BIOMA

IMMUN

Xiaoyi Sun China

Roberto Palomba Italy

Ergang Liu China

Young Min Kwon United States

Huining He China

William Ho United States

Chunxiong Zheng China

B.J. Kim United States

Sabine Barnert Germany

Xiaoyi Sun China

Dalit Landesman‐Milo

441 ×0.7

239 ×0.8

BIOMA

242 ×1.0

176 ×0.7

IMMUN

90 ×0.7

Citations per year, relative to Dalit Landesman‐Milo Dalit Landesman‐Milo (= 1×) peers Xiaoyi Sun

Countries citing papers authored by Dalit Landesman‐Milo

Since Specialization

Citations

This map shows the geographic impact of Dalit Landesman‐Milo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dalit Landesman‐Milo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dalit Landesman‐Milo more than expected).

Fields of papers citing papers by Dalit Landesman‐Milo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dalit Landesman‐Milo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dalit Landesman‐Milo. The network helps show where Dalit Landesman‐Milo may publish in the future.

Co-authorship network of co-authors of Dalit Landesman‐Milo

This figure shows the co-authorship network connecting the top 25 collaborators of Dalit Landesman‐Milo. A scholar is included among the top collaborators of Dalit Landesman‐Milo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dalit Landesman‐Milo. Dalit Landesman‐Milo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Singh, Manu Smriti, Srinivas Ramishetti, Dalit Landesman‐Milo, et al.. (2021). Therapeutic Gene Silencing Using Targeted Lipid Nanoparticles in Metastatic Ovarian Cancer. Small. 17(19). e2100287–e2100287. 46 indexed citations

Singh, Manu Smriti, Srinivas Ramishetti, Dalit Landesman‐Milo, et al.. (2021). Gene Silencing: Therapeutic Gene Silencing Using Targeted Lipid Nanoparticles in Metastatic Ovarian Cancer (Small 19/2021). Small. 17(19). 1 indexed citations

Singh, Manu Smriti, Meir Goldsmith, Sushmita Chatterjee, et al.. (2019). An ovarian spheroid based tumor model that represents vascularized tumors and enables the investigation of nanomedicine therapeutics. Nanoscale. 12(3). 1894–1903. 21 indexed citations

Landesman‐Milo, Dalit, et al.. (2018). Combined reflectance spectroscopy and coherent light backscattering measurement differentiate cervical cancer from normal epithelial tissue in a xenograft mouse model. Applied Optics. 57(30). 8964–8964. 2 indexed citations

Mizrahy, Shoshy, Inbal Hazan‐Halevy, Niels Dammes, Dalit Landesman‐Milo, & Dan Peer. (2017). Current Progress in Non-viral RNAi-Based Delivery Strategies to Lymphocytes. Molecular Therapy. 25(7). 1491–1500. 45 indexed citations

Mizrahy, Shoshy, et al.. (2017). Advanced Strategies in Immune Modulation of Cancer Using Lipid-Based Nanoparticles. Frontiers in Immunology. 8. 69–69. 31 indexed citations

Hazan‐Halevy, Inbal, et al.. (2016). Immunomodulation of hematological malignancies using oligonucleotides based-nanomedicines. Journal of Controlled Release. 244(Pt B). 149–156. 18 indexed citations

Landesman‐Milo, Dalit & Dan Peer. (2016). Transforming Nanomedicines From Lab Scale Production to Novel Clinical Modality. Bioconjugate Chemistry. 27(4). 855–862. 65 indexed citations

Ramishetti, Srinivas, Dalit Landesman‐Milo, & Dan Peer. (2016). Advances in RNAi therapeutic delivery to leukocytes using lipid nanoparticles. Journal of drug targeting. 24(9). 780–786. 29 indexed citations

10.

Landesman‐Milo, Dalit, Srinivas Ramishetti, & Dan Peer. (2015). Nanomedicine as an emerging platform for metastatic lung cancer therapy. Cancer and Metastasis Reviews. 34(2). 291–301. 60 indexed citations

11.

Azagury, Aharon, Riki Goldbart, Tamar Traitel, et al.. (2014). Quaternized starch-based carrier for siRNA delivery: From cellular uptake to gene silencing. Journal of Controlled Release. 185. 109–120. 53 indexed citations

12.

Landesman‐Milo, Dalit & Dan Peer. (2013). Toxicity profiling of several common RNAi-based nanomedicines: a comparative study. Drug Delivery and Translational Research. 4(1). 96–103. 56 indexed citations

13.

Emmanuel, Rafi, Shiri Weinstein, Dalit Landesman‐Milo, & Dan Peer. (2013). eIF3c: A potential therapeutic target for cancer. Cancer Letters. 336(1). 158–166. 31 indexed citations

14.

Landesman‐Milo, Dalit, Meir Goldsmith, Shani Leviatan Ben‐Arye, et al.. (2012). Hyaluronan grafted lipid-based nanoparticles as RNAi carriers for cancer cells. Cancer Letters. 334(2). 221–227. 55 indexed citations

15.

Moyano, Daniel F., Meir Goldsmith, Dalit Landesman‐Milo, et al.. (2012). Nanoparticle Hydrophobicity Dictates Immune Response. Journal of the American Chemical Society. 134(9). 3965–3967. 394 indexed citations

16.

Landesman‐Milo, Dalit & Dan Peer. (2011). Altering the immune response with lipid-based nanoparticles. Journal of Controlled Release. 161(2). 600–608. 113 indexed citations

17.

Landesman‐Milo, Dalit, Bogdan Belgorodsky, Moran Frenkel‐Pinter, et al.. (2011). Enhanced Bioavailability of Polyaromatic Hydrocarbons in the Form of Mucin Complexes. Chemical Research in Toxicology. 24(3). 314–320. 11 indexed citations

18.

Landesman‐Milo, Dalit, Manju Surana, Amelia Compagni, et al.. (2001). Correction of Hyperglycemia in Diabetic Mice Transplanted with Reversibly Immortalized Pancreatic β Cells Controlled by the tet-on Regulatory System. Cell Transplantation. 10(7). 645–650. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact